Both Diaphage and Cidophage Retard are used to treat type 2 diabetes. They contain the same active ingredient, but at different concentrations and dosage forms, which affects the speed of drug release and the frequency of administration. Understanding these differences helps determine the most appropriate product for each patient.
Diaphage Tablet Ingredients
Diaphage tablets contain the active ingredient metformin hydrochloride, 1000 mg per tablet in this example. Metformin is a biguanide that works by reducing glucose production in the liver, increasing insulin sensitivity in muscles, and improving glucose absorption from the intestine. Metformin is known to be the most commonly recommended first-line treatment for type 2 diabetes.
Cidophage Retard Tablet Ingredients
Cidophage Retard tablets also contain the active ingredient metformin hydrochloride, but at a concentration of 850 mg per tablet in this example. The word "Retard" or "SR" refers to "extended release" or "sustained release." This means that the medication is released slowly in the gastrointestinal tract over a longer period, allowing it to be taken fewer times per day and potentially reducing some gastrointestinal side effects.
About Diaphage Tablets
Drug Class: Biguanides
Drug Classification: Biguanide
Pharmaceutical Form: Coated Tablets
Pharmaceutical Family: Diabetes Treatment
Active Ingredient: Metformin Hydrochloride (1000 mg)
About Cidophage Retard Tablets
Drug Class: Biguanides
Drug Classification: Biguanide
Pharmaceutical Form: Extended-Release (SR) Tablets
Pharmaceutical Family: Diabetes Treatment
Active Ingredient: Metformin Hydrochloride (850 mg)